Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_12824 | 21 | 0.44 | Mlig455_015782, Mlig455_045748 | Neo: - Age: - |
NPY1R | Mlig455_015782 {REF} {Length: 771} {NoTransDecoderORF} {RNA1310_145549} Mlig455_045748 {REF} {Length: 3703} {tRNA: Val(CAC),pseudo, score=23.6} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=128.8]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.1]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=125, Expect=2e-31]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=124, Expect=3e-31]; ENSMUSG00000048337, Npy4r, neuropeptide Y receptor Y4, [Score=123, Expect=4e-31]; ENSMUSG00000028004, Npy2r, neuropeptide Y receptor Y2, [Score=119, Expect=2e-29]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=161, Expect=2e-44]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=137, Expect=4e-36]} {Smed: dd_Smed_v6_16725_0_1, dd_Smed_v6_16725_0_1, [Score=228, Expect=7e-70]} {RNA1509_45595} {RNA1310_56759} {RNA815_43101} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.551 | 0.791 | 0.99975 | 1.00000 | |
RegionR2 | 4.823 | 0.791 | 0.74767 | 1.00000 | |
RegionR3 | -0.786 | 0.791 | 0.99975 | 1.00000 | |
RegionR4 | -1.238 | 0.791 | 0.89530 | 1.00000 | |
RegionR5 | -1.162 | 0.791 | 0.99999 | 1.00000 | |
RegionR6 | -0.741 | 0.791 | 0.99975 | 1.00000 | |
RegionR7 | -0.212 | 0.791 | 0.99980 | 1.00000 | |
RegionR8 | -0.134 | 0.791 | 0.99985 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 0.988 | 0.791 | 0.99988 | 1.00000 | |
RegenerationR2 | 1.062 | 0.791 | 0.17148 | 0.61064 | |
RegenerationR3 | 3.812 | 0.791 | 0.55670 | 0.88709 | |
RegenerationR4 | 0.585 | 0.791 | 0.96828 | 1.00000 | |
RegenerationR5 | 2.052 | 0.791 | 0.46758 | 0.84084 | |
RegenerationR6 | 0.702 | 0.791 | 1.00000 | 1.00000 | |
RegenerationBL | 0.608 | 0.791 | 1.00000 | 1.00000 | |
RegenerationTP | 0.357 | 0.791 | 1.00000 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_12824 | 21 | 0.44 | Mlig455_015782, Mlig455_045748 | Neo: - Age: - |
NPY1R | 3 | 1.000 | - | - | - | 1.000 | 1.000 | Mlig455_015782 {REF} {Length: 771} {NoTransDecoderORF} {RNA1310_145549} Mlig455_045748 {REF} {Length: 3703} {tRNA: Val(CAC),pseudo, score=23.6} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=128.8]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.1]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=125, Expect=2e-31]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=124, Expect=3e-31]; ENSMUSG00000048337, Npy4r, neuropeptide Y receptor Y4, [Score=123, Expect=4e-31]; ENSMUSG00000028004, Npy2r, neuropeptide Y receptor Y2, [Score=119, Expect=2e-29]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=161, Expect=2e-44]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=137, Expect=4e-36]} {Smed: dd_Smed_v6_16725_0_1, dd_Smed_v6_16725_0_1, [Score=228, Expect=7e-70]} {RNA1509_45595} {RNA1310_56759} {RNA815_43101} |
2. | MligTC455_40905 | 53 | 1.1 | Mlig455_002794, Mlig455_002809 | Neo: - Age: - |
CHL1 | 2.85 | 0.891 | - | - | - | 0.988 | 0.971 | Mlig455_002794 {REF} {Length: 4845} {Pfam: Immunoglobulin domain [PF13927.8, score=205.6]; Immunoglobulin I-set domain [PF07679.18, score=151.2]; Immunoglobulin domain [PF00047.27, score=122.8]; Immunoglobulin domain [PF13895.8, score=109.6]; Fibronectin type III domain [PF00041.23, score=98.8]; Immunoglobulin V-set domain [PF07686.19, score=65.4]; Immunoglobulin domain [PF18452.3, score=21.7]} {Human: ENSG00000134121, CHL1, cell adhesion molecule L1 like, [RH, Score=340, Expect=1e-96]} {Mouse: ENSMUSG00000031391, L1cam, L1 cell adhesion molecule, [RH, Score=339, Expect=2e-96]; ENSMUSG00000030077, Chl1, cell adhesion molecule L1-like, [RH, Score=335, Expect=4e-95]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=358, Expect=2e-103]} {Celegans: WBGene00002243, lad-2, Immunoglobulin domain-containing protein Y54G2A.25; L1 CAM ADhesion molecule homolog; LAD-2 long isoform, [Score=287, Expect=1e-79]} {Smed: dd_Smed_v6_1916_0_1, dd_Smed_v6_1916_0_1, [Score=486, Expect=3e-148]} {RNA1310_42673} Mlig455_002809 {REF} {Length: 4785} {Pfam: Immunoglobulin domain [PF13927.8, score=155.8]; Immunoglobulin I-set domain [PF07679.18, score=111.7]; Fibronectin type III domain [PF00041.23, score=99.0]; Immunoglobulin domain [PF00047.27, score=90.9]; Immunoglobulin domain [PF13895.8, score=77.2]; Immunoglobulin V-set domain [PF07686.19, score=38.0]} {Human: ENSG00000134121, CHL1, cell adhesion molecule L1 like, [Score=292, Expect=8e-81]; ENSG00000163531, NFASC, neurofascin, [Score=290, Expect=4e-80]} {Mouse: ENSMUSG00000031391, L1cam, L1 cell adhesion molecule, [Score=294, Expect=2e-81]; ENSMUSG00000026442, Nfasc, neurofascin, [Score=290, Expect=2e-80]; ENSMUSG00000030077, Chl1, cell adhesion molecule L1-like, [Score=285, Expect=2e-78]; ENSMUSG00000020598, Nrcam, neuronal cell adhesion molecule, [Score=282, Expect=7e-78]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=315, Expect=1e-88]} {Celegans: WBGene00002243, lad-2, Immunoglobulin domain-containing protein Y54G2A.25; L1 CAM ADhesion molecule homolog; LAD-2 long isoform, [Score=251, Expect=9e-68]} {Smed: dd_Smed_v6_1916_0_1, dd_Smed_v6_1916_0_1, [Score=441, Expect=4e-132]} {RNA1310_42673} |
3. | MligTC455_24951 | 220 | 4.58 | Mlig455_052169 | Neo: - Age: - Region-specific R2: 4.554 Region-enriched R2: 4.264/0.00008 Regeneration-downregulated R2: -1.743 Regeneration-depleted R2: -1.743 |
CCDC169 | 2.833 | 0.983 | - | - | - | 0.935 | 0.915 | Mlig455_052169 {REF} {Length: 1369} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} |
4. | MligTC455_14829 | 56 | 1.17 | Mlig455_053237 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=1.599 Region-enriched R2: 3.828/0.03404 |
SSUH2 | 2.814 | 0.973 | - | - | - | 0.952 | 0.889 | Mlig455_053237 {REF} {Length: 1420} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=156, Expect=2e-43]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=117, Expect=2e-29]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=87.4, Expect=9e-19]} {RNA1509_46058} {RNA1310_5028.1} {RNA815_5650} |
5. | MligTC455_47704 | 106 | 2.21 | Mlig455_032247 | Neo: - |
WSCD2 | 2.798 | 0.971 | - | - | - | 0.977 | 0.850 | Mlig455_032247 {REF} {Length: 2305} {Pfam: WSC domain [PF01822.21, score=58.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=54.7, Expect=1e-07]; ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.8, Expect=5e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.6, Expect=3e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.9, Expect=1e-10]} {RNA1509_59284} {RNA1310_13567} {RNA815_27780} |
6. | MligTC455_24952 | 637 | 13.28 | Mlig455_054178, Mlig455_060727 | Neo: - Age: Down-Up-Down Region-specific R2: 4.165 Region-enriched R2: 3.160/0.00003 Regeneration-downregulated BL: -4.774 Regeneration-depleted BL: -4.774 |
CCDC169 | 2.797 | 0.972 | - | - | - | 0.954 | 0.871 | Mlig455_054178 {REF} {Length: 1390} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} Mlig455_060727 {REF} {Length: 1391} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029, RNA1509_8270} {RNA1509_8270, RNA815_11545} |
7. | MligTC455_43557 | 362 | 7.55 | Mlig455_059172, Mlig455_065527 | Neo: - Age: Down-Down-Up Region-specific R2: 6.284 Region-enriched R2: 5.832/0.00001 |
ANKRD63 | 2.788 | 0.954 | - | - | - | 0.903 | 0.931 | Mlig455_059172 {REF} {Length: 1739} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.2]; Ankyrin repeats (many copies) [PF13637.8, score=42.6]; Ankyrin repeat [PF13606.8, score=27.6]; Ankyrin repeats (many copies) [PF13857.8, score=27.1]; Ankyrin repeat [PF00023.32, score=25.9]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [Score=68.2, Expect=7e-12]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [Score=67.4, Expect=7e-12]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=49.3, Expect=7e-06]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=49.3, Expect=4e-06]} {Smed: dd_Smed_v6_10280_0_1, dd_Smed_v6_10280_0_1, [Score=81.3, Expect=1e-16]} {RNA1310_44826} {RNA815_62096} Mlig455_065527 {REF} {Length: 2998} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=52.3]; Ankyrin repeats (many copies) [PF13637.8, score=42.0]; Ankyrin repeats (many copies) [PF13857.8, score=26.7]; Ankyrin repeat [PF00023.32, score=26.0]; Ankyrin repeat [PF13606.8, score=22.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [Score=68.2, Expect=7e-12]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [Score=68.2, Expect=6e-12]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=50.1, Expect=5e-06]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=50.4, Expect=2e-06]} {Smed: dd_Smed_v6_10280_0_1, dd_Smed_v6_10280_0_1, [Score=80.9, Expect=2e-16]} {RNA1509_30872} {RNA1310_44826} {RNA815_62096} |
8. | MligTC455_52507 | 60 | 1.26 | Mlig455_016440 | Neo: - Age: - Region-enriched R2: 5.871/0.01204 |
2.772 | 0.906 | - | - | - | 0.907 | 0.959 | Mlig455_016440 {REF} {Length: 1576} {Pfam: PAN domain [PF00024.28, score=19.3]} {RNA1310_98267} | |
9. | MligTC455_35802 | 114 | 2.38 | Mlig455_051876, Mlig455_051902, Mlig455_053140 | Neo: - Age: - |
CACNA2D1 | 2.767 | 0.809 | - | - | - | 0.993 | 0.965 | Mlig455_051876 {REF} {Length: 3144} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=89.1]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=84.7, Expect=2e-16]} {RNA1509_55590} {RNA1310_60852} {RNA815_15380} Mlig455_051902 {REF} {Length: 4662} {Pfam: VWA N-terminal [PF08399.13, score=90.4]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.6]; von Willebrand factor type A domain [PF00092.30, score=38.6]; Cache domain [PF02743.20, score=27.5]; von Willebrand factor type A domain [PF13519.8, score=26.5]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=326, Expect=8e-94]} {Mouse: ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=326, Expect=7e-94]} {Dmel: FBgn0261041, stj, straightjacket, [Score=229, Expect=7e-61]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=141, Expect=9e-34]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=153, Expect=1e-37]} {RNA1509_55590} {RNA1310_7325.1, RNA1509_55590} {RNA1509_55590, RNA815_14878} Mlig455_053140 {REF} {Length: 3265} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.9]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=87.0, Expect=8e-17]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=50.4, Expect=9e-06]} {RNA1509_55590} {RNA1310_7325.1} {RNA815_14878} |
10. | MligTC455_54282 | 74 | 1.54 | Mlig455_020191 | Neo: - Age: - |
2.75 | 0.928 | - | - | - | 0.858 | 0.964 | Mlig455_020191 {REF} {Length: 937} {RNA1509_48973} {RNA1310_40738.2} {RNA815_31898} | |
11. | MligTC455_33636 | 175 | 3.64 | Mlig455_027209, Mlig455_050659 | Neo: - Age: logFC(26M/2M)=-0.416 Region-enriched R2: 3.904/0.00709 |
CHRNA10 | 2.712 | 0.820 | - | - | - | 0.933 | 0.959 | Mlig455_027209 {REF} {Length: 1614} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=99.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=74.0]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=152, Expect=1e-40]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=150, Expect=8e-40]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=148, Expect=6e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=150, Expect=3e-40]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=150, Expect=5e-40]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=144, Expect=5e-38]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=133, Expect=1e-33]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=142, Expect=3e-37]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=142, Expect=3e-37]} {RNA1310_19147.1} {RNA815_8553.1} Mlig455_050659 {REF} {Length: 1670} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=69.9]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=144, Expect=1e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=141, Expect=1e-36]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=9e-37]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=134, Expect=4e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=7e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=141, Expect=6e-37]} {RNA1310_19147.1} {RNA815_8553.1} |
12. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 2.689 | 0.775 | - | - | - | 0.952 | 0.962 | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
13. | MligTC455_15546 | 141 | 2.93 | Mlig455_021744 | Neo: - Age: - |
2.685 | 0.978 | - | - | - | 0.837 | 0.870 | Mlig455_021744 {REF} {Length: 1839} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=60.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=26.5]} {Mouse: ENSMUSG00000039079, Trhr2, thyrotropin releasing hormone receptor 2, [Score=51.2, Expect=1e-06]} {Dmel: FBgn0053696, CNMaR, CNMamide Receptor, [Score=72.0, Expect=3e-13]} {Celegans: WBGene00020586, frpr-18, FLP-2 receptor; FMRFamide Peptide Receptor family, [Score=69.3, Expect=2e-12]} {Smed: dd_Smed_v6_25364_0_1, dd_Smed_v6_25364_0_1, [RH, Score=197, Expect=7e-59]} {RNA1310_26850} {RNA815_17444} | |
14. | MligTC455_50927 | 254 | 5.29 | Mlig455_070541, Mlig455_070562 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.296 Region-enriched R2: 7.883/0.00008 |
FZD4 | 2.674 | 0.900 | - | - | - | 0.818 | 0.956 | Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571} Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571} |
15. | MligTC455_19248 | 238 | 4.95 | Mlig455_036051 | Neo: - Age: - Region-enriched R2: 8.870/0.00000 |
2.658 | 0.807 | - | - | - | 0.891 | 0.960 | Mlig455_036051 {REF} {Length: 807} {RNA1509_57448} {RNA1310_51394} {RNA815_26076} | |
16. | MligTC455_47393 | 241 | 5.03 | Mlig455_008718, Mlig455_063579 | Neo: - Age: Down-Up-Down Region-enriched R2: 3.683/0.00849 |
CALM2 | 2.657 | 0.784 | - | - | - | 0.913 | 0.960 | Mlig455_008718 {REF} {Length: 1727} {Pfam: EF hand [PF00036.34, score=99.3]; EF-hand domain pair [PF13499.8, score=95.1]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13833.8, score=76.8]; EF hand [PF13202.8, score=75.3]; EF-hand domain [PF14658.8, score=46.0]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.9]; EF-hand domain [PF08976.13, score=23.4]; Uncharacterised protein family (UPF0154) [PF03672.15, score=18.7]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=108, Expect=4e-30]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=4e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=4e-30]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-30]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=108, Expect=2e-30]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=1e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-30]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-30]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=114, Expect=8e-33]} {RNA1310_33847.1} {RNA815_17211} Mlig455_063579 {REF} {Length: 2562} {Pfam: EF hand [PF00036.34, score=95.8]; EF-hand domain pair [PF13499.8, score=92.8]; EF-hand domain [PF13405.8, score=82.9]; EF-hand domain pair [PF13833.8, score=74.4]; EF hand [PF13202.8, score=72.2]; EF-hand domain [PF14658.8, score=43.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.6]; EF-hand domain [PF08976.13, score=21.4]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=111, Expect=7e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=3e-29]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=3e-29]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=111, Expect=7e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-29]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-29]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=9e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-29]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-29]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=111, Expect=9e-31]} {RNA1310_12431.1} {RNA815_17211} |
17. | MligTC455_16907 | 87 | 1.82 | Mlig455_008705 | Neo: - Age: Down-Up-Down |
SLC17A8 | 2.645 | 0.748 | - | - | - | 0.961 | 0.936 | Mlig455_008705 {REF} {Length: 1949} {Pfam: Major Facilitator Superfamily [PF07690.18, score=37.9]; SOCE-associated regulatory factor of calcium homoeostasis [PF06682.14, score=19.6]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [Score=213, Expect=1e-65]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [Score=212, Expect=1e-64]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [Score=208, Expect=6e-64]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [Score=215, Expect=1e-67]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [Score=211, Expect=1e-64]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [Score=207, Expect=4e-63]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=196, Expect=1e-58]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=189, Expect=1e-56]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [Score=234, Expect=3e-73]} {RNA1509_38152} {RNA1310_19607.1} {RNA815_14894} |
18. | MligTC455_15467 | 225 | 4.69 | Mlig455_000546 | Neo: - Age: Down-Up-Up Region-specific R2: 6.857 Region-enriched R2: 5.997/0.00105 |
2.637 | 0.815 | - | - | - | 0.960 | 0.862 | Mlig455_000546 {REF} {Length: 844} {Pfam: Pancreatic hormone peptide [PF00159.20, score=42.9]} {Smed: dd_Smed_v6_16946_0_1, dd_Smed_v6_16946_0_1, [Score=39.7, Expect=1e-05]} {RNA1310_53697} {RNA815_26198} | |
19. | MligTC455_34925 | 183 | 3.82 | Mlig455_012715 | Neo: - Age: - |
CDKL1 | 2.603 | 0.773 | - | - | - | 0.960 | 0.870 | Mlig455_012715 {REF} {Length: 2370} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=250.2]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=120.6]; RIO1 family [PF01163.24, score=23.0]; ABC1 atypical kinase-like domain [PF03109.18, score=20.8]; Haspin like kinase domain [PF12330.10, score=20.4]; Kinase-like [PF14531.8, score=19.4]} {Human: ENSG00000100490, CDKL1, cyclin dependent kinase like 1, [RH, Score=437, Expect=3e-153]; ENSG00000205111, CDKL4, cyclin dependent kinase like 4, [RH, Score=424, Expect=2e-147]} {Mouse: ENSMUSG00000020990, Cdkl1, cyclin-dependent kinase-like 1 (CDC2-related kinase), [RH, Score=437, Expect=2e-153]; ENSMUSG00000033966, Cdkl4, cyclin-dependent kinase-like 4, [RH, Score=432, Expect=2e-151]} {Dmel: FBgn0031730, CG7236, [RH, Score=384, Expect=3e-131]} {Celegans: WBGene00012779, cdkl-1, Cyclin-Dependent Kinase-Like, [RH, Score=388, Expect=3e-132]} {Smed: dd_Smed_v6_9353_0_1, dd_Smed_v6_9353_0_1, [RH, Score=472, Expect=5e-167]} {RNA1509_44617} {RNA1310_15038, RNA1509_44617} {RNA1509_44617, RNA815_6379} |
20. | MligTC455_54202 | 381 | 7.94 | Mlig455_006349 | Neo: - Age: logFC(26M/2M)=0.343 Region-specific R2: 5.916 Region-enriched R2: 5.229/0.00037 |
MYH6 | 2.579 | 0.966 | - | - | - | 0.806 | 0.807 | Mlig455_006349 {REF} {Length: 6943} {Pfam: Myosin head (motor domain) [PF00063.23, score=929.0]; Myosin tail [PF01576.21, score=591.7]; Myosin N-terminal SH3-like domain [PF02736.21, score=60.7]; Crescentin protein [PF19220.2, score=26.4]; Autophagy protein 16 (ATG16) [PF08614.13, score=20.3]; Macoilin family [PF09726.11, score=18.3]} {Human: ENSG00000197616, MYH6, myosin heavy chain 6, [RH, Score=2075, Expect=0.0]; ENSG00000092054, MYH7, myosin heavy chain 7, [RH, Score=2066, Expect=0.0]; ENSG00000125414, MYH2, myosin heavy chain 2, [RH, Score=2021, Expect=0.0]; ENSG00000109061, MYH1, myosin heavy chain 1, [RH, Score=2013, Expect=0.0]; ENSG00000133020, MYH8, myosin heavy chain 8, [RH, Score=2007, Expect=0.0]; ENSG00000264424, MYH4, myosin heavy chain 4, [RH, Score=1993, Expect=0.0]; ENSG00000109063, MYH3, myosin heavy chain 3, [RH, Score=1974, Expect=0.0]} {Mouse: ENSMUSG00000040752, Myh6, myosin, heavy polypeptide 6, cardiac muscle, alpha, [RH, Score=2076, Expect=0.0]; ENSMUSG00000053093, Myh7, myosin, heavy polypeptide 7, cardiac muscle, beta, [RH, Score=2063, Expect=0.0]; ENSMUSG00000057003, Myh4, myosin, heavy polypeptide 4, skeletal muscle, [RH, Score=2041, Expect=0.0]; ENSMUSG00000056328, Myh1, myosin, heavy polypeptide 1, skeletal muscle, adult, [RH, Score=2018, Expect=0.0]; ENSMUSG00000055775, Myh8, myosin, heavy polypeptide 8, skeletal muscle, perinatal, [RH, Score=2015, Expect=0.0]; ENSMUSG00000033196, Myh2, myosin, heavy polypeptide 2, skeletal muscle, adult, [RH, Score=2009, Expect=0.0]; ENSMUSG00000020908, Myh3, myosin, heavy polypeptide 3, skeletal muscle, embryonic, [RH, Score=1981, Expect=0.0]; ENSMUSG00000060180, Myh13, myosin, heavy polypeptide 13, skeletal muscle, [RH, Score=1979, Expect=0.0]} {Dmel: FBgn0264695, Mhc, Myosin heavy chain, [RH, Score=2100, Expect=0.0]} {Celegans: WBGene00019064, myo-5, MYOsin heavy chain structural genes, [RH, Score=1996, Expect=0.0]} {Smed: dd_Smed_v6_579_0_1, dd_Smed_v6_579_0_1, [RH, Score=2705, Expect=0.0]} {RNA1509_16048, RNA1509_54239, RNA1509_55838} {RNA1310_1388, RNA1509_16048, RNA1509_54239, RNA1509_55838} {RNA1509_16048, RNA1509_54239, RNA1509_55838, RNA815_129.1} |
21. | MligTC455_52813 | 47 | 0.99 | Mlig455_045013 | Neo: - Age: logFC(26M/2M)=1.210 |
CNTN2 | 2.547 | 0.719 | - | - | - | 0.959 | 0.869 | Mlig455_045013 {REF} {Length: 3626} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=57.7]; Immunoglobulin domain [PF13927.8, score=52.5]; Immunoglobulin domain [PF13895.8, score=40.3]; Immunoglobulin domain [PF00047.27, score=40.1]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=25.8]} {Human: ENSG00000184144, CNTN2, contactin 2, [Score=59.3, Expect=2e-08]} {Mouse: ENSMUSG00000053024, Cntn2, contactin 2, [Score=57.4, Expect=5e-08]; ENSMUSG00000061751, Kalrn, kalirin, RhoGEF kinase, [Score=55.5, Expect=2e-07]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=55.1, Expect=2e-07]} {Smed: dd_Smed_v6_15129_0_1, dd_Smed_v6_15129_0_1, [RH, Score=99.4, Expect=2e-22]} {RNA1509_60115} {RNA1310_31768} {RNA815_18728} |
22. | MligTC455_40051 | 36 | 0.76 | Mlig455_025990 | Neo: - Age: logFC(26M/2M)=-0.633 |
PRKCE | 1.988 | 0.991 | - | - | - | 0.997 | - | Mlig455_025990 {REF} {Length: 2622} {Pfam: Protein kinase domain [PF00069.27, score=102.7]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=69.5]; Kinase-like [PF14531.8, score=19.5]} {Human: ENSG00000171132, PRKCE, protein kinase C epsilon, [Score=84.3, Expect=1e-16]} {Mouse: ENSMUSG00000045038, Prkce, protein kinase C, epsilon, [Score=82.0, Expect=5e-16]} {Dmel: FBgn0283472, S6k, Ribosomal protein S6 kinase, [Score=79.0, Expect=2e-15]} {Celegans: WBGene00009793, pkn-1, Protein Kinase N (PKN) homolog, [Score=73.2, Expect=2e-13]} {Smed: dd_Smed_v6_8010_0_1, dd_Smed_v6_8010_0_1, [Score=77.8, Expect=4e-15]} {RNA1509_36146} {RNA1310_24732} {RNA815_64704} |
23. | MligTC455_23961 | 12 | 0.24 | Mlig455_001329 | Neo: - Age: - |
SLC6A1 | 1.975 | - | - | - | - | 0.992 | 0.983 | Mlig455_001329 {REF} {Length: 2800} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=486.0]} {Human: ENSG00000157103, SLC6A1, solute carrier family 6 member 1, [Score=378, Expect=3e-123]; ENSG00000165970, SLC6A5, solute carrier family 6 member 5, [Score=370, Expect=9e-118]} {Mouse: ENSMUSG00000030310, Slc6a1, solute carrier family 6 (neurotransmitter transporter, GABA), member 1, [Score=377, Expect=3e-123]; ENSMUSG00000030108, Slc6a13, solute carrier family 6 (neurotransmitter transporter, GABA), member 13, [Score=370, Expect=2e-120]; ENSMUSG00000039728, Slc6a5, solute carrier family 6 (neurotransmitter transporter, glycine), member 5, [Score=369, Expect=1e-117]; ENSMUSG00000030109, Slc6a12, solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12, [Score=360, Expect=3e-116]} {Dmel: FBgn0034136, DAT, Dopamine transporter, [Score=356, Expect=1e-114]} {Celegans: WBGene00000934, dat-1, Sodium-dependent dopamine transporter, [Score=340, Expect=7e-109]} {Smed: dd_Smed_v6_8169_0_1, dd_Smed_v6_8169_0_1, [Score=350, Expect=8e-113]} {RNA1509_32034} {RNA1310_45592} {RNA815_60993} |
24. | MligTC455_15134 | 15 | 0.31 | Mlig455_000804 | Neo: - Age: - |
CNGA3 | 1.972 | 1.000 | - | - | - | 0.972 | - | Mlig455_000804 {REF} {Length: 2294} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=62.8]; Ion transport protein [PF00520.33, score=39.4]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [Score=351, Expect=2e-113]; ENSG00000198515, CNGA1, cyclic nucleotide gated channel alpha 1, [Score=344, Expect=2e-110]; ENSG00000183862, CNGA2, cyclic nucleotide gated channel alpha 2, [Score=340, Expect=2e-109]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [Score=352, Expect=9e-115]; ENSMUSG00000067220, Cnga1, cyclic nucleotide gated channel alpha 1, [Score=342, Expect=7e-110]; ENSMUSG00000005864, Cnga2, cyclic nucleotide gated channel alpha 2, [Score=338, Expect=9e-109]} {Dmel: FBgn0259145, CG42260, [Score=463, Expect=1e-153]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=281, Expect=1e-86]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [Score=343, Expect=2e-111]} {RNA1310_120793} {RNA815_25814} |
25. | MligTC455_14519 | 25 | 0.51 | Mlig455_005304 | Neo: - Age: - |
1.97 | 1.000 | - | - | - | 0.970 | - | Mlig455_005304 {REF} {Length: 1686} {RNA1509_3030} {RNA1310_65512} {RNA815_48423} | |
26. | MligTC455_15253 | 11 | 0.22 | Mlig455_010266 | Neo: - Age: - |
1.963 | - | - | - | - | 0.997 | 0.966 | Mlig455_010266 {REF} {Length: 252} {NoTransDecoderORF} {RNA815_48483} | |
27. | MligTC455_31463 | 20 | 0.42 | Mlig455_057169 | Neo: - Age: - |
1.958 | 1.000 | - | - | - | 0.958 | - | Mlig455_057169 {REF} {Length: 1647} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=39.0]} {Smed: dd_Smed_v6_12148_0_2, dd_Smed_v6_12148_0_2, [Score=82.4, Expect=3e-18]} {RNA1509_6604} {RNA1310_43619} {RNA815_6128.2} | |
28. | MligTC455_25412 | 199 | 4.15 | Mlig455_008720, Mlig455_063581 | Neo: - Age: - Region-enriched R2: 7.484/0.00035 |
CNBD2 | 1.956 | 0.971 | - | - | - | 0.985 | - | Mlig455_008720 {REF} {Length: 2602} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=82.1]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=52.4, Expect=3e-06]} {Smed: dd_Smed_v6_13623_0_1, dd_Smed_v6_13623_0_1, [Score=241, Expect=1e-69]} {RNA1509_50931} {RNA1310_3304} {RNA815_12767} Mlig455_063581 {REF} {Length: 2668} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=82.3]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=52.4, Expect=3e-06]} {Smed: dd_Smed_v6_13623_0_1, dd_Smed_v6_13623_0_1, [Score=241, Expect=7e-70]} {RNA1509_50931} {RNA1310_3304} {RNA815_12767} |
29. | MligTC455_14598 | 52 | 1.07 | Mlig455_058970 | Neo: - Age: - |
1.954 | - | - | - | - | 0.993 | 0.961 | Mlig455_058970 {REF} {Length: 1038} {RNA1310_39570} {RNA815_52309} | |
30. | MligTC455_53937 | 44 | 0.92 | Mlig455_021975, Mlig455_022028 | Neo: - Age: - |
1.954 | 0.979 | - | - | - | 0.975 | - | Mlig455_021975 {REF} {Length: 631} {NoTransDecoderORF} {RNA1310_130902} Mlig455_022028 {REF} {Length: 192} {NoTransDecoderORF} {RNA1310_130902} |
|
31. | MligTC455_27785 | 115 | 2.39 | Mlig455_001141 | Neo: - |
HMCN2 | 1.951 | 1.000 | - | - | - | 0.951 | - | Mlig455_001141 {REF} {Length: 2156} {Pfam: von Willebrand factor type A domain [PF13519.8, score=54.7]; von Willebrand factor type A domain [PF13768.8, score=30.6]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=81.3, Expect=2e-15]} {Mouse: ENSMUSG00000007030, Vwa7, von Willebrand factor A domain containing 7, [Score=79.0, Expect=6e-15]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=77.8, Expect=2e-14]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=96.3, Expect=1e-20]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=79.7, Expect=2e-15]} {RNA1509_38050} {RNA1310_19586} {RNA815_17693} |
32. | MligTC455_18161 | 771 | 16.05 | Mlig455_031626, Mlig455_048205 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.318/0.00160 |
1.95 | 0.977 | - | - | - | 0.973 | - | Mlig455_031626 {REF} {Length: 835} {TRANSSPLICED} {RNA1509_48514} {RNA1310_56583, RNA1509_48514} {RNA1509_48514, RNA815_34758} Mlig455_048205 {REF} {Length: 651} {RNA1509_48514} {RNA1310_56583} {RNA815_34758} |
|
33. | MligTC455_45039 | 168 | 3.49 | Mlig455_040482, Mlig455_040487 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.332/0.02336 |
1.95 | 1.000 | - | - | - | - | 0.950 | Mlig455_040482 {REF} {Length: 1774} {RNA1310_20941} {RNA815_45079} Mlig455_040487 {REF} {Length: 5763} {tRNA: Val(CAC),pseudo, score=20.2} {Celegans: WBGene00022195, Y71H2B.5, [Score=146, Expect=8e-36]} {Smed: dd_Smed_v6_16438_0_2, dd_Smed_v6_16438_0_2, [Score=188, Expect=1e-49]} {RNA1509_21228} {RNA1310_20941} {RNA815_45079} |
|
34. | MligTC455_09224 | 21 | 0.43 | Mlig455_038078 | Neo: - Age: - |
1.949 | 1.000 | - | - | - | - | 0.949 | Mlig455_038078 {REF} {Length: 771} {Pfam: PAN domain [PF00024.28, score=28.0]} {RNA1509_46267} {RNA1310_51656} {RNA815_32275.1} | |
35. | MligTC455_03731 | 113 | 2.35 | Mlig455_066791 | Neo: - Age: - |
1.946 | 0.968 | - | - | - | 0.978 | - | Mlig455_066791 {REF} {Length: 1679} {Smed: dd_Smed_v6_13648_0_1, dd_Smed_v6_13648_0_1, [RH, Score=79.7, Expect=2e-16]} {RNA1509_58026} {RNA1310_23180, RNA1509_58026} {RNA1509_58026, RNA815_34008} | |
36. | MligTC455_25928 | 181 | 3.78 | Mlig455_006534, Mlig455_006538, Mlig455_006649, Mlig455_006700 | Neo: - Age: logFC(26M/2M)=-0.528 Region-specific R2: 7.256 Region-enriched R2: 5.788/0.02697 |
1.944 | - | - | - | - | 0.998 | 0.946 | Mlig455_006534 {REF} {Length: 689} {RNA1509_22927} {RNA1310_81957.1} {RNA815_41771.2} Mlig455_006538 {REF} {Length: 1691} {RNA1509_12380} {RNA1310_164.2} {RNA815_19957} Mlig455_006649 {REF} {Length: 829} {RNA1509_22927} {RNA1310_81957.1} {RNA815_41771.2} Mlig455_006700 {REF} {Length: 750} {RNA1509_22927} {RNA1310_81957.2} {RNA815_41771.2} |
|
37. | MligTC455_15329 | 22 | 0.47 | Mlig455_060498 | Neo: - Age: - |
1.938 | - | - | - | - | 0.977 | 0.961 | Mlig455_060498 {REF} {Length: 1186} {Pfam: PAN domain [PF00024.28, score=18.9]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=63.9, Expect=4e-12]} {RNA1310_37660} {RNA815_17816.1} | |
38. | MligTC455_46188 | 25 | 0.51 | Mlig455_039664, Mlig455_039727 | Neo: - Age: - |
1.938 | - | - | - | - | 0.994 | 0.944 | Mlig455_039664 {REF} {Length: 1353} Mlig455_039727 {REF} {Length: 1348} |
|
39. | MligTC455_52493 | 6 | 0.13 | Mlig455_058213 | Neo: - Age: - |
1.935 | 0.985 | - | - | - | 0.950 | - | Mlig455_058213 {REF} {Length: 1454} {Smed: dd_Smed_v6_25969_0_1, dd_Smed_v6_25969_0_1, [Score=79.0, Expect=3e-16]} {RNA1310_119010} | |
40. | MligTC455_38355 | 110 | 2.29 | Mlig455_039715, Mlig455_039769 | Neo: - Age: - |
KCNB2 | 1.934 | - | - | - | - | 0.999 | 0.935 | Mlig455_039715 {REF} {Length: 3883} {Pfam: Ion transport protein [PF00520.33, score=114.4]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=43.6]} {Human: ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=218, Expect=3e-60]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=213, Expect=2e-60]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=213, Expect=7e-59]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=210, Expect=2e-59]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=7e-59]} {Mouse: ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=219, Expect=5e-61]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=218, Expect=1e-60]; ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=214, Expect=8e-61]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=213, Expect=6e-60]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=230, Expect=8e-67]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=236, Expect=3e-69]} {Smed: dd_Smed_v6_11886_0_1, dd_Smed_v6_11886_0_1, [RH, Score=592, Expect=0.0]} {RNA1509_22940} {RNA1310_17926} {RNA815_8687.1} Mlig455_039769 {REF} {Length: 4176} {Pfam: Ion transport protein [PF00520.33, score=116.7]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=43.6]; Polycystin cation channel [PF08016.14, score=20.7]} {Human: ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=219, Expect=8e-61]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=216, Expect=2e-61]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=215, Expect=2e-59]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=213, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=213, Expect=4e-60]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=210, Expect=4e-58]} {Mouse: ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=221, Expect=2e-61]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=219, Expect=4e-61]; ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=216, Expect=6e-62]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=215, Expect=6e-61]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=211, Expect=1e-58]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=231, Expect=2e-67]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=239, Expect=2e-70]} {Smed: dd_Smed_v6_11886_0_1, dd_Smed_v6_11886_0_1, [RH, Score=595, Expect=0.0]} {RNA1509_22940} {RNA1310_17926} {RNA815_8687.1} |
41. | MligTC455_48064 | 23 | 0.48 | Mlig455_061550 | Neo: - Age: - |
1.931 | - | - | - | - | 0.988 | 0.943 | Mlig455_061550 {REF} {Length: 860} {RNA1310_88363} {RNA815_47885} | |
42. | MligTC455_08774 | 25 | 0.53 | Mlig455_001889 | Neo: - Age: Up-Down-Down |
HCRTR2 | 1.93 | - | - | - | - | 0.958 | 0.972 | Mlig455_001889 {REF} {Length: 3436} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=160.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=30.4]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=24.1]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=215, Expect=2e-63]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [RH, Score=212, Expect=1e-62]} {Dmel: FBgn0038874, ETHR, [Score=142, Expect=6e-37]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=116, Expect=6e-28]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=202, Expect=1e-59]} {RNA1310_31833} {RNA815_15909} |
43. | MligTC455_52746 | 33 | 0.7 | Mlig455_036774 | Neo: - Age: - |
1.926 | - | - | - | - | 0.963 | 0.963 | Mlig455_036774 {REF} {Length: 1992} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=90.0]} {Smed: dd_Smed_v6_16274_0_1, dd_Smed_v6_16274_0_1, [Score=77.4, Expect=7e-15]} {RNA1310_26715} {RNA815_32348} | |
44. | MligTC455_33442 | 39 | 0.81 | Mlig455_039767 | Neo: - Age: - |
1.92 | 0.982 | - | - | - | 0.938 | - | Mlig455_039767 {REF} {Length: 1975} {RNA1310_42391} | |
45. | MligTC455_29412 | 46 | 0.96 | Mlig455_000627, Mlig455_008268, Mlig455_040614 | Neo: - Age: Up-Down-Up |
1.919 | - | - | - | - | 0.981 | 0.938 | Mlig455_000627 {REF} {Length: 1331} {RNA1310_62571} {RNA815_30942} Mlig455_008268 {REF} {Length: 1779} {RNA1509_47298} {RNA1310_98344} {RNA815_10804.1} Mlig455_040614 {REF} {Length: 1016} |
|
46. | MligTC455_40065 | 58 | 1.22 | Mlig455_069280 | Neo: - Age: Up-Down-Up |
1.917 | - | - | - | - | 0.958 | 0.959 | Mlig455_069280 {REF} {Length: 3092} {Pfam: Coiled-coil domain-containing protein 154 [PF15450.8, score=35.7]; Apolipoprotein A1/A4/E domain [PF01442.20, score=19.3]} {Smed: dd_Smed_v6_10236_0_1, dd_Smed_v6_10236_0_1, [Score=236, Expect=1e-67]} {RNA1509_48196} {RNA1310_30411, RNA1509_48196} {RNA1509_48196, RNA815_45200} | |
47. | MligTC455_48128 | 18 | 0.37 | Mlig455_052326 | Neo: - Age: - |
1.914 | 0.972 | - | - | - | 0.942 | - | Mlig455_052326 {REF} {Length: 3582} {RNA1310_42908} {RNA815_22744} | |
48. | MligTC455_46502 | 168 | 3.5 | Mlig455_010557 | Neo: - Age: - |
1.913 | 0.925 | - | - | - | 0.988 | - | Mlig455_010557 {REF} {Length: 557} {Pfam: HalX domain [PF08663.12, score=24.3]} {RNA1509_57107} {RNA1310_80026, RNA1509_57107} {RNA1509_57107, RNA815_41799} | |
49. | MligTC455_16847 | 1240 | 25.83 | Mlig455_051898, Mlig455_053146 | Neo: - Age: Down-Up-Down Region-specific R2: 5.478 Region-enriched R2: 5.690/0.00000 |
PRSS33 | 1.913 | - | - | - | - | 0.945 | 0.968 | Mlig455_051898 {REF} {Length: 1360} {Pfam: Trypsin [PF00089.28, score=189.8]; Domain of unknown function (DUF1986) [PF09342.13, score=27.3]; Trypsin-like peptidase domain [PF13365.8, score=26.9]} {Human: ENSG00000103355, PRSS33, serine protease 33, [Score=159, Expect=4e-46]} {Mouse: ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [Score=153, Expect=9e-41]; ENSMUSG00000037129, Tmprss13, transmembrane protease, serine 13, [Score=150, Expect=2e-40]; ENSMUSG00000059406, Tmprss9, transmembrane protease, serine 9, [Score=148, Expect=6e-39]; ENSMUSG00000022857, Tmprss15, transmembrane protease, serine 15, [Score=147, Expect=2e-38]} {Dmel: FBgn0036287, CG10663, [Score=146, Expect=1e-38]} {Celegans: WBGene00006620, svh-1, HGF/MSP/plasminogen-like protein, [Score=124, Expect=6e-31]} {Smed: dd_Smed_v6_10267_0_1, dd_Smed_v6_10267_0_1, [Score=178, Expect=4e-53]} {RNA1509_29335} {RNA1310_23561} {RNA815_9840} Mlig455_053146 {REF} {Length: 1448} {Pfam: Trypsin [PF00089.28, score=189.8]; Domain of unknown function (DUF1986) [PF09342.13, score=27.3]; Trypsin-like peptidase domain [PF13365.8, score=26.9]} {Human: ENSG00000103355, PRSS33, serine protease 33, [Score=159, Expect=4e-46]} {Mouse: ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [Score=153, Expect=9e-41]; ENSMUSG00000037129, Tmprss13, transmembrane protease, serine 13, [Score=150, Expect=2e-40]; ENSMUSG00000059406, Tmprss9, transmembrane protease, serine 9, [Score=148, Expect=6e-39]; ENSMUSG00000022857, Tmprss15, transmembrane protease, serine 15, [Score=147, Expect=2e-38]} {Dmel: FBgn0036287, CG10663, [Score=146, Expect=1e-38]} {Celegans: WBGene00006620, svh-1, HGF/MSP/plasminogen-like protein, [Score=124, Expect=6e-31]} {Smed: dd_Smed_v6_10267_0_1, dd_Smed_v6_10267_0_1, [Score=178, Expect=4e-53]} {RNA1509_26566, RNA1509_29335} {RNA1310_23561, RNA1509_26566, RNA1509_29335} {RNA1509_26566, RNA1509_29335, RNA815_9840} |
50. | MligTC455_15726 | 270 | 5.63 | Mlig455_031204 | Neo: - Age: - Region-enriched R2: 6.820/0.00015 |
ADAMTS18 | 1.911 | 0.978 | - | - | - | 0.933 | - | Mlig455_031204 {REF} {Length: 2405} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=77.6]; Metallo-peptidase family M12 [PF13688.8, score=52.5]; Metallo-peptidase family M12B Reprolysin-like [PF13583.8, score=45.6]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=41.4]; ADAM cysteine-rich domain [PF17771.3, score=40.0]; Metallo-peptidase family M12B Reprolysin-like [PF13574.8, score=30.9]; Astacin (Peptidase family M12A) [PF01400.26, score=19.3]} {Human: ENSG00000140873, ADAMTS18, ADAM metallopeptidase with thrombospondin type 1 motif 18, [Score=90.9, Expect=1e-18]} {Mouse: ENSMUSG00000049538, Adamts16, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 16, [Score=90.1, Expect=1e-18]; ENSMUSG00000053399, Adamts18, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18, [Score=89.7, Expect=2e-18]} {Dmel: FBgn0034903, sona, sol narae, [RH, Score=114, Expect=7e-27]} {Celegans: WBGene00003248, mig-17, ADAM family mig-17, [RH, Score=100, Expect=2e-22]} {RNA1509_42775} {RNA1310_19585.1, RNA1509_42775} {RNA1509_42775, RNA815_17997} |
51. | MligTC455_19249 | 90 | 1.86 | Mlig455_054092 | Neo: - Age: Down-Up-Up Region-enriched R2: 7.298/0.00139 |
1.911 | - | - | - | - | 0.972 | 0.939 | Mlig455_054092 {REF} {Length: 667} {TRANSSPLICED} {RNA1509_57448} {RNA1310_51394, RNA1509_57448} {RNA1509_57448, RNA815_26076} | |
52. | MligTC455_32422 | 37 | 0.78 | Mlig455_031348 | Neo: - Age: - |
CHRNA6 | 1.91 | 0.995 | - | - | - | 0.915 | - | Mlig455_031348 {REF} {Length: 1659} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=69.7]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=61.6, Expect=5e-10]; ENSG00000160716, CHRNB2, cholinergic receptor nicotinic beta 2 subunit, [Score=61.2, Expect=8e-10]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=61.2, Expect=5e-10]; ENSMUSG00000027950, Chrnb2, cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal), [Score=60.8, Expect=8e-10]; ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=58.5, Expect=4e-09]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [Score=48.5, Expect=4e-06]} {Celegans: WBGene00000057, acr-18, AcetylCholine Receptor; Acetylcholine receptor, one of nine alpha a7-like nicotinic acetylcholine receptor subunits (58.6 kD) (Acr-18), [Score=63.5, Expect=5e-11]} {Smed: dd_Smed_v6_30253_0_1, dd_Smed_v6_30253_0_1, [Score=59.3, Expect=6e-10]} {RNA1310_61084} {RNA815_48984} |
53. | MligTC455_19079 | 218 | 4.54 | Mlig455_008746, Mlig455_008760 | Neo: - Age: Down-Up-Up Region-specific R2: 6.705 Region-enriched R2: 6.864/0.00152 |
1.91 | - | - | - | - | 0.952 | 0.958 | Mlig455_008746 {REF} {Length: 652} {RNA1310_75395.1} {RNA815_42524} Mlig455_008760 {REF} {Length: 1051} {RNA1310_75395.1} {RNA815_42524} |
|
54. | MligTC455_12438 | 17 | 0.35 | Mlig455_009594 | Neo: - Age: - |
1.909 | - | - | - | - | 0.984 | 0.925 | Mlig455_009594 {REF} {Length: 2044} {RNA1310_39190} {RNA815_29274} | |
55. | MligTC455_13165 | 181 | 3.77 | Mlig455_018648 | Neo: - Age: - Region-specific R2: 6.131 Region-enriched R2: 4.463/0.01828 Regeneration-downregulated R2: -3.253 Regeneration-depleted R2: -3.253 |
1.909 | 0.933 | - | - | - | 0.976 | - | Mlig455_018648 {REF} {Length: 1920} {TRANSSPLICED} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=209.8]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=21.6]; FAD binding domain [PF01494.21, score=20.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.9]; FAD binding domain [PF00890.26, score=18.9]} {Mouse: ENSMUSG00000033624, Pdpr, pyruvate dehydrogenase phosphatase regulatory subunit, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [RH, Score=246, Expect=2e-77]} {RNA1509_25789} {RNA1310_15994} {RNA815_21830} | |
56. | MligTC455_38775 | 266 | 5.54 | Mlig455_066758, Mlig455_069705 | Neo: - Age: - Region-specific R2: 6.147 Region-enriched R2: 5.505/0.02411 |
WNT6 | 1.908 | - | - | - | - | 0.981 | 0.927 | Mlig455_066758 {REF} {Length: 2739} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=9e-15]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=6e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=74.3, Expect=9e-14]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.9, Expect=4e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=71.2, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.2} {RNA815_8552} Mlig455_069705 {REF} {Length: 2713} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=1e-14]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=7e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=73.9, Expect=1e-13]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.6, Expect=6e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=70.9, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.1, RNA1509_23528} {RNA1509_23528, RNA815_8552} |
57. | MligTC455_29874 | 65 | 1.36 | Mlig455_037947, Mlig455_068699 | Neo: - Age: logFC(26M/2M)=-0.467 |
ANKRD50 | 1.907 | - | - | - | - | 0.960 | 0.947 | Mlig455_037947 {REF} {Length: 4099} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=309.9]; Ankyrin repeat [PF00023.32, score=295.0]; Ankyrin repeat [PF13606.8, score=230.6]; Ankyrin repeats (many copies) [PF13637.8, score=228.6]; Ankyrin repeats (many copies) [PF13857.8, score=200.7]; Glutamine amidotransferase domain [PF13537.8, score=68.9]; PEGA domain [PF08308.13, score=35.0]; Mab-21 protein [PF03281.16, score=29.5]; Nucleoplasmin/nucleophosmin domain [PF03066.17, score=26.4]} {Human: ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=276, Expect=2e-75]; ENSG00000029534, ANK1, ankyrin 1, [Score=270, Expect=5e-73]} {Mouse: ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=274, Expect=8e-75]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=256, Expect=7e-69]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=258, Expect=1e-69]} {Smed: dd_Smed_v6_2072_0_29, dd_Smed_v6_2072_0_29, [Score=256, Expect=2e-71]} {RNA1509_26004, RNA1509_28959} {RNA1310_3906.1, RNA1509_28959} {RNA1509_28959, RNA815_1664.1} Mlig455_068699 {REF} {Length: 2234} {Pfam: Mab-21 protein [PF03281.16, score=31.1]} {RNA1509_26004} {RNA1310_3906.1} {RNA815_1664.1} |
58. | MligTC455_13030 | 30 | 0.63 | Mlig455_030520 | Neo: - Age: - |
1.901 | - | - | - | - | 0.986 | 0.915 | Mlig455_030520 {REF} {Length: 3950} {RNA1509_41925} {RNA1310_32300.1, RNA1509_41925} {RNA1509_41925, RNA815_29217} | |
59. | MligTC455_27186 | 28 | 0.57 | Mlig455_010236 | Neo: - Age: logFC(26M/2M)=-1.855 |
1.901 | 1.000 | - | - | - | 0.901 | - | Mlig455_010236 {REF} {Length: 486} {RNA1509_7146} {RNA1310_76234.2} {RNA815_34947.2} | |
60. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 1.901 | - | - | - | - | 0.938 | 0.963 | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
61. | MligTC455_44120 | 125 | 2.61 | Mlig455_041513 | Neo: - Age: Up-Down-Down Region-enriched R2: 7.169/0.00020 |
1.9 | - | - | - | - | 0.940 | 0.960 | Mlig455_041513 {REF} {Length: 644} {NoTransDecoderORF} {RNA1310_39164} {RNA815_4344} | |
62. | MligTC455_53414 | 331 | 6.9 | Mlig455_053442 | Neo: - Age: - Region-specific R2: 4.308 Region-enriched R2: 3.374/0.00040 |
RP1 | 1.899 | - | - | - | - | 0.938 | 0.961 | Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1} |
63. | MligTC455_12991 | 30 | 0.62 | Mlig455_037487 | Neo: - Age: - |
CHRNA6 | 1.896 | - | - | - | - | 0.952 | 0.944 | Mlig455_037487 {REF} {Length: 1592} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=70.8]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=55.6]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=119, Expect=5e-29]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=110, Expect=4e-26]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=109, Expect=3e-25]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=107, Expect=5e-25]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=107, Expect=8e-25]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=106, Expect=2e-24]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=111, Expect=4e-26]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=111, Expect=1e-26]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=112, Expect=5e-27]} {RNA1310_100091} {RNA815_18433} |
64. | MligTC455_43676 | 56 | 1.16 | Mlig455_058053, Mlig455_058096 | Neo: - Age: - |
1.896 | 1.000 | - | - | - | 0.896 | - | Mlig455_058053 {REF} {Length: 391} {NoTransDecoderORF} {RNA1509_25254} {RNA1310_102705} {RNA815_52459} Mlig455_058096 {REF} {Length: 1983} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=51.3]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [Score=90.1, Expect=1e-19]} {RNA1509_1472} {RNA1310_25467} {RNA815_39314} |
|
65. | MligTC455_44712 | 665 | 13.86 | Mlig455_017186 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.471 Region-specific R2: 4.141 Region-enriched R2: 3.536/0.00000 |
1.896 | - | - | - | - | 0.945 | 0.951 | Mlig455_017186 {REF} {Length: 1018} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
66. | MligTC455_45580 | 42 | 0.88 | Mlig455_010918 | Neo: - Age: Down-Down-Down |
1.893 | - | - | - | - | 0.933 | 0.960 | Mlig455_010918 {REF} {Length: 2621} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=86.4]; Anti-sigma-K factor rskA [PF10099.11, score=25.8]} {Smed: dd_Smed_v6_16346_0_1, dd_Smed_v6_16346_0_1, [Score=78.6, Expect=5e-15]} {RNA1310_36429} {RNA815_37174} | |
67. | MligTC455_19876 | 135 | 2.82 | Mlig455_024520, Mlig455_024523 | Neo: - Age: - |
1.893 | - | - | - | - | 0.955 | 0.938 | Mlig455_024520 {REF} {Length: 2352} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} Mlig455_024523 {REF} {Length: 2311} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=153, Expect=3e-47]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} |
|
68. | MligTC455_35000 | 20 | 0.42 | Mlig455_050562 | Neo: - Age: - |
KCNC1 | 1.892 | 0.961 | - | - | - | 0.931 | - | Mlig455_050562 {REF} {Length: 3042} {Pfam: Ion transport protein [PF00520.33, score=116.8]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=42.0]} {Human: ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=211, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=1e-58]; ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=206, Expect=3e-56]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=204, Expect=3e-57]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=204, Expect=1e-55]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=203, Expect=7e-56]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=212, Expect=3e-60]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=209, Expect=2e-57]; ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=206, Expect=2e-56]; ENSMUSG00000027895, Kcnc4, potassium voltage gated channel, Shaw-related subfamily, member 4, [Score=204, Expect=4e-57]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=203, Expect=1e-56]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=203, Expect=4e-56]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=223, Expect=2e-65]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=224, Expect=8e-65]} {Smed: dd_Smed_v6_20858_0_1, dd_Smed_v6_20858_0_1, [RH, Score=567, Expect=0.0]} {RNA1509_22940} {RNA1310_28483} {RNA815_31040} |
69. | MligTC455_46924 | 1562 | 32.53 | Mlig455_042561 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.240 Region-enriched R2: 5.226/0.00021 |
PI16 | 1.891 | - | - | - | - | 0.938 | 0.953 | Mlig455_042561 {REF} {Length: 1929} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=59.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=75.5, Expect=4e-14]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=78.6, Expect=3e-15]; ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=75.1, Expect=5e-15]} {Dmel: FBgn0038126, CG8483, [Score=65.9, Expect=2e-11]} {Celegans: WBGene00003055, lon-1, LONg, [Score=65.9, Expect=7e-12]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=140, Expect=2e-36]} {RNA1509_33691, RNA1509_4403} {RNA1310_19427.1, RNA1509_33691, RNA1509_4403} {RNA1509_33691, RNA1509_4403, RNA815_7689.1} |
70. | MligTC455_35739 | 91 | 1.9 | Mlig455_050779 | Neo: - Age: Up-Down-Down |
ADGRL2 | 1.89 | - | - | - | - | 0.983 | 0.907 | Mlig455_050779 {REF} {Length: 4277} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=110.1]; Pentaxin family [PF00354.19, score=43.4]; Hormone receptor domain [PF02793.24, score=35.9]; Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=33.0]; GPCR-Autoproteolysis INducing (GAIN) domain [PF16489.7, score=20.5]; Myc amino-terminal region [PF01056.20, score=18.8]} {Human: ENSG00000117114, ADGRL2, adhesion G protein-coupled receptor L2, [RH, Score=140, Expect=5e-33]; ENSG00000072071, ADGRL1, adhesion G protein-coupled receptor L1, [RH, Score=139, Expect=2e-32]; ENSG00000150471, ADGRL3, adhesion G protein-coupled receptor L3, [RH, Score=133, Expect=9e-31]} {Mouse: ENSMUSG00000028184, Adgrl2, adhesion G protein-coupled receptor L2, [RH, Score=142, Expect=1e-33]; ENSMUSG00000013033, Adgrl1, adhesion G protein-coupled receptor L1, [RH, Score=140, Expect=6e-33]} {Celegans: WBGene00002252, lat-2, Latrophilin-like protein LAT-2, [RH, Score=124, Expect=2e-28]} {Smed: dd_Smed_v6_16446_0_2, dd_Smed_v6_16446_0_2, [RH, Score=444, Expect=1e-139]} {RNA1509_25495} {RNA1310_3070} {RNA815_2153} |
71. | MligTC455_27216 | 56 | 1.18 | Mlig455_022418 | Neo: - |
TRPM3 | 1.888 | - | - | - | - | 0.950 | 0.938 | Mlig455_022418 {REF} {Length: 4794} {Pfam: SLOG in TRPM [PF18139.3, score=136.8]; Ion transport protein [PF00520.33, score=41.0]; SLOG in TRPM, prokaryote [PF18171.3, score=34.2]} {Human: ENSG00000083067, TRPM3, transient receptor potential cation channel subfamily M member 3, [Score=317, Expect=2e-88]; ENSG00000119121, TRPM6, transient receptor potential cation channel subfamily M member 6, [Score=316, Expect=4e-88]} {Mouse: ENSMUSG00000052387, Trpm3, transient receptor potential cation channel, subfamily M, member 3, [Score=319, Expect=4e-90]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=309, Expect=7e-88]} {Celegans: WBGene00001796, gtl-2, Gon-Two Like (TRP subfamily), [Score=255, Expect=4e-69]} {Smed: dd_Smed_v6_9288_0_1, dd_Smed_v6_9288_0_1, [Score=418, Expect=3e-126]} {RNA1509_17593} {RNA1310_1651, RNA1509_17593} {RNA1509_17593, RNA815_2281} |
72. | MligTC455_29915 | 50 | 1.04 | Mlig455_027934 | Neo: - Age: Down-Up-Up Region-enriched R2: 6.881/0.04464 |
ANGPTL1 | 1.888 | - | - | - | - | 0.924 | 0.964 | Mlig455_027934 {REF} {Length: 2265} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=43.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=48.9, Expect=9e-06]} {Dmel: FBgn0031804, CG9500, [Score=53.1, Expect=9e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=49.7, Expect=1e-06]} {RNA1509_53291} {RNA1310_38229.1} {RNA815_10579.1} |
73. | MligTC455_44922 | 15 | 0.31 | Mlig455_040611 | Neo: - Age: - |
AC254952.1 | 1.887 | 0.966 | - | - | - | 0.921 | - | Mlig455_040611 {REF} {Length: 1658} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=86.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=85.3]} {Human: ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=152, Expect=1e-40]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=152, Expect=2e-40]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=152, Expect=2e-40]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=147, Expect=9e-39]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=129, Expect=1e-32]} {Celegans: WBGene00001133, eat-2, Neuronal acetylcholine receptor subunit eat-2, [Score=136, Expect=2e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=136, Expect=2e-35]} {RNA1310_45581} {RNA815_21574} |
74. | MligTC455_31462 | 23 | 0.48 | Mlig455_000844 | Neo: - Age: - |
1.886 | 0.928 | - | - | - | 0.958 | - | Mlig455_000844 {REF} {Length: 2564} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=39.1]} {Smed: dd_Smed_v6_12148_0_2, dd_Smed_v6_12148_0_2, [Score=81.6, Expect=5e-18]} {RNA1509_6604} {RNA1310_43619} {RNA815_6128.2} | |
75. | MligTC455_45021 | 381 | 7.95 | Mlig455_046686 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.428/0.03156 |
AVP | 1.886 | - | - | - | - | 0.919 | 0.967 | Mlig455_046686 {REF} {Length: 1388} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.2]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=54.3, Expect=2e-09]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=53.1, Expect=3e-09]} {RNA1509_50574} {RNA1310_38922} {RNA815_23813} |
76. | MligTC455_22212 | 1732 | 36.09 | Mlig455_009239, Mlig455_009645, Mlig455_037058 | Neo: - Age: logFC(26M/2M)=-0.722 Region-specific R2: 6.329 Region-enriched R2: 6.728/0.00000 |
LMNA | 1.885 | 0.915 | - | - | - | 0.970 | - | Mlig455_009239 {REF} {Length: 2842} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286} {RNA1310_9741.1} {RNA815_3167} Mlig455_009645 {REF} {Length: 2337} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286} {RNA1310_9741.1} {RNA815_3167} Mlig455_037058 {REF} {Length: 4944} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286, RNA1509_31019, RNA1509_37437} {RNA1310_9741.1, RNA1509_18286, RNA1509_31019, RNA1509_37437} {RNA1509_18286, RNA1509_31019, RNA1509_37437, RNA815_3167} |
77. | MligTC455_25072 | 4443 | 92.56 | Mlig455_015899 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.175 Region-enriched R2: 4.389/0.00000 |
PI16 | 1.885 | - | - | - | - | 0.927 | 0.958 | Mlig455_015899 {REF} {Length: 2017} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=112, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=5e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.5, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=5e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_5027} {RNA1310_1356.1} {RNA815_4508} |
78. | MligTC455_45861 | 18 | 0.38 | Mlig455_034439 | Neo: - Age: - |
1.883 | - | - | - | - | 0.954 | 0.929 | Mlig455_034439 {REF} {Length: 1135} {RNA1310_86023} | |
79. | MligTC455_14310 | 27 | 0.56 | Mlig455_021495 | Neo: - Age: - Regeneration-upregulated R2: 3.309 Regeneration-enriched R2: 3.309 |
1.881 | - | - | - | - | 0.986 | 0.895 | Mlig455_021495 {REF} {Length: 4005} {RNA1509_54101} {RNA1310_16857} {RNA815_29628} | |
80. | MligTC455_13166 | 186 | 3.88 | Mlig455_018849 | Neo: - Age: - Region-specific R2: 6.227 |
1.88 | 0.911 | - | - | - | 0.969 | - | Mlig455_018849 {REF} {Length: 693} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=209.8]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=21.6]; FAD binding domain [PF01494.21, score=20.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.9]; FAD binding domain [PF00890.26, score=18.9]} {Mouse: ENSMUSG00000033624, Pdpr, pyruvate dehydrogenase phosphatase regulatory subunit, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [RH, Score=246, Expect=2e-77]} {RNA1509_49819} {RNA1310_28647} {RNA815_1682.1} | |
81. | MligTC455_41226 | 44 | 0.92 | Mlig455_019357, Mlig455_059122 | Neo: - Age: - |
GALNT1 | 1.88 | - | - | - | - | 0.911 | 0.969 | Mlig455_019357 {REF} {Length: 1606} {Pfam: Glycosyl transferase family 2 [PF00535.28, score=97.5]; Glycosyltransferase like family 2 [PF13641.8, score=38.9]; N-terminal domain of galactosyltransferase [PF02709.16, score=29.1]; Glycosyltransferase like family 2 [PF10111.11, score=18.5]} {Human: ENSG00000141429, GALNT1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=318, Expect=2e-103]; ENSG00000139629, GALNT6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=311, Expect=4e-100]; ENSG00000257594, GALNT4, polypeptide N-acetylgalactosaminyltransferase 4, [Score=305, Expect=3e-98]; ENSG00000259075, POC1B-GALNT4, POC1B-GALNT4 readthrough, [Score=305, Expect=3e-98]} {Mouse: ENSMUSG00000000420, Galnt1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=316, Expect=1e-102]; ENSMUSG00000037280, Galnt6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=308, Expect=9e-99]; ENSMUSG00000060988, Galnt13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=302, Expect=3e-97]} {Dmel: FBgn0050463, CG30463, [Score=345, Expect=5e-113]} {Celegans: WBGene00001630, gly-5, Polypeptide N-acetylgalactosaminyltransferase 5, [Score=350, Expect=3e-115]} {Smed: dd_Smed_v6_8580_0_1, dd_Smed_v6_8580_0_1, [Score=353, Expect=1e-117]} {RNA1310_25598} {RNA815_36943} Mlig455_059122 {REF} {Length: 2150} {Pfam: Glycosyl transferase family 2 [PF00535.28, score=96.4]; Glycosyltransferase like family 2 [PF13641.8, score=35.9]; N-terminal domain of galactosyltransferase [PF02709.16, score=29.5]} {Human: ENSG00000141429, GALNT1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=313, Expect=2e-101]; ENSG00000139629, GALNT6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=307, Expect=2e-98]; ENSG00000257594, GALNT4, polypeptide N-acetylgalactosaminyltransferase 4, [Score=300, Expect=6e-96]; ENSG00000259075, POC1B-GALNT4, POC1B-GALNT4 readthrough, [Score=299, Expect=7e-96]; ENSG00000144278, GALNT13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=298, Expect=1e-95]} {Mouse: ENSMUSG00000000420, Galnt1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=311, Expect=1e-100]; ENSMUSG00000037280, Galnt6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=305, Expect=1e-97]; ENSMUSG00000060988, Galnt13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=298, Expect=8e-96]; ENSMUSG00000026994, Galnt3, polypeptide N-acetylgalactosaminyltransferase 3, [Score=296, Expect=5e-94]; ENSMUSG00000026828, Galnt5, polypeptide N-acetylgalactosaminyltransferase 5, [Score=296, Expect=2e-91]} {Dmel: FBgn0050463, CG30463, [Score=340, Expect=3e-111]} {Celegans: WBGene00001630, gly-5, Polypeptide N-acetylgalactosaminyltransferase 5, [Score=344, Expect=3e-113]} {Smed: dd_Smed_v6_8580_0_1, dd_Smed_v6_8580_0_1, [Score=350, Expect=3e-116]} {RNA1310_25598} {RNA815_36943} |
82. | MligTC455_15836 | 36 | 0.74 | Mlig455_000292 | Neo: - Age: Up-Down-Down |
PLEKHG5 | 1.879 | - | - | - | - | 0.962 | 0.917 | Mlig455_000292 {REF} {Length: 4512} {Pfam: RhoGEF domain [PF00621.22, score=89.5]; PH domain [PF17838.3, score=20.5]; Pleckstrin homology domain [PF15405.8, score=19.2]} {Human: ENSG00000171680, PLEKHG5, pleckstrin homology and RhoGEF domain containing G5, [Score=197, Expect=6e-52]} {Mouse: ENSMUSG00000039713, Plekhg5, pleckstrin homology domain containing, family G (with RhoGef domain) member 5, [Score=199, Expect=5e-53]} {Dmel: FBgn0261556, CG42674, [Score=147, Expect=6e-36]} {Celegans: WBGene00006476, rhgf-2, RHGF-2; RHo Guanine nucleotide exchange Factor, [RH, Score=147, Expect=3e-36]} {Smed: dd_Smed_v6_10072_0_1, dd_Smed_v6_10072_0_1, [RH, Score=179, Expect=8e-48]} {RNA1310_47096} {RNA815_53026} |
83. | MligTC455_26322 | 65 | 1.35 | Mlig455_042546 | Neo: - Age: - |
GRID2 | 1.879 | - | - | - | - | 0.920 | 0.959 | Mlig455_042546 {REF} {Length: 3217} {Pfam: Ligand-gated ion channel [PF00060.28, score=79.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=49.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=35.5]; Receptor family ligand binding region [PF01094.30, score=33.7]} {Human: ENSG00000152208, GRID2, glutamate ionotropic receptor delta type subunit 2, [Score=127, Expect=3e-29]} {Mouse: ENSMUSG00000071424, Grid2, glutamate receptor, ionotropic, delta 2, [Score=129, Expect=5e-30]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=133, Expect=1e-31]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=105, Expect=6e-23]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=238, Expect=8e-71]} {RNA1310_27694} {RNA815_34664} |
84. | MligTC455_31104 | 22 | 0.46 | Mlig455_040032, Mlig455_070983 | Neo: - Age: - |
SYT17 | 1.879 | - | - | - | - | 0.900 | 0.979 | Mlig455_040032 {REF} {Length: 2712} {Pfam: C2 domain [PF00168.32, score=79.2]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=127, Expect=1e-30]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=126, Expect=1e-30]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=88.6, Expect=2e-18]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=94.0, Expect=1e-20]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [Score=96.7, Expect=3e-21]} {RNA1310_17303} Mlig455_070983 {REF} {Length: 1947} {Pfam: C2 domain [PF00168.32, score=79.2]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=127, Expect=1e-30]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=126, Expect=1e-30]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=88.6, Expect=2e-18]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=94.0, Expect=1e-20]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [Score=96.7, Expect=3e-21]} {RNA1310_17303} |
85. | MligTC455_49862 | 26 | 0.54 | Mlig455_019435 | Neo: - Age: - |
SHOX2 | 1.878 | - | - | - | - | 0.971 | 0.907 | Mlig455_019435 {REF} {Length: 904} {Pfam: Homeodomain [PF00046.31, score=84.8]; Homeobox KN domain [PF05920.13, score=23.6]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=89.0, Expect=4e-22]; ENSG00000185960, SHOX, short stature homeobox, [Score=87.0, Expect=5e-21]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=89.0, Expect=3e-22]} {Dmel: FBgn0085396, CG34367, [Score=89.7, Expect=9e-22]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=83.6, Expect=5e-20]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=86.3, Expect=2e-20]} {RNA1310_51707} {RNA815_41055} |
86. | MligTC455_43454 | 36 | 0.74 | Mlig455_043999 | Neo: - Age: - |
1.876 | - | - | - | - | 0.980 | 0.896 | Mlig455_043999 {REF} {Length: 2456} {Dmel: FBgn0259222, CG42322, [RH, Score=101, Expect=3e-22]} {Smed: dd_Smed_v6_18554_0_1, dd_Smed_v6_18554_0_1, [Score=82.4, Expect=1e-17]} {RNA1310_20749} {RNA815_38231} | |
87. | MligTC455_26411 | 55 | 1.14 | Mlig455_024911 | Neo: - Age: - |
1.874 | 0.961 | - | - | - | 0.913 | - | Mlig455_024911 {REF} {Length: 2411} {Pfam: SH3 domain [PF00018.30, score=28.9]; Variant SH3 domain [PF14604.8, score=22.2]; Variant SH3 domain [PF07653.19, score=22.1]} {Smed: dd_Smed_v6_8729_0_1, dd_Smed_v6_8729_0_1, [RH, Score=60.1, Expect=5e-10]} {RNA1310_32104} {RNA815_32970} | |
88. | MligTC455_52935 | 29 | 0.61 | Mlig455_014479 | Neo: - Age: - |
PROX1 | 1.874 | 0.909 | - | - | - | 0.965 | - | Mlig455_014479 {REF} {Length: 1320} {Pfam: Homeo-prospero domain [PF05044.14, score=192.8]} {Human: ENSG00000117707, PROX1, prospero homeobox 1, [Score=163, Expect=5e-44]; ENSG00000119608, PROX2, prospero homeobox 2, [Score=159, Expect=4e-43]} {Mouse: ENSMUSG00000010175, Prox1, prospero homeobox 1, [Score=163, Expect=4e-44]; ENSMUSG00000042320, Prox2, prospero homeobox 2, [Score=162, Expect=2e-44]} {Dmel: FBgn0004595, pros, prospero, [Score=182, Expect=1e-50]} {Celegans: WBGene00000448, pros-1, Homeobox protein prospero homolog 1, [Score=178, Expect=1e-50]} {Smed: dd_Smed_v6_48508_0_1, dd_Smed_v6_48508_0_1, [Score=165, Expect=9e-50]} {RNA1310_102283} |
89. | MligTC455_44904 | 1501 | 31.27 | Mlig455_021814 | Neo: - Age: Down-Up-Up Region-specific R2: 3.865 Region-enriched R2: 3.792/0.00000 |
1.872 | - | - | - | - | 0.978 | 0.894 | Mlig455_021814 {REF} {Length: 959} {RNA1509_15805} {RNA1310_67099.1, RNA1509_15805} {RNA1509_15805, RNA815_17533} | |
90. | MligTC455_54204 | 344 | 7.17 | Mlig455_006398 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=0.351 Region-specific R2: 5.395 Region-enriched R2: 4.187/0.01201 |
MYH6 | 1.872 | - | - | - | - | 0.903 | 0.969 | Mlig455_006398 {REF} {Length: 7465} {Pfam: Myosin head (motor domain) [PF00063.23, score=927.6]; Myosin tail [PF01576.21, score=593.3]; Myosin N-terminal SH3-like domain [PF02736.21, score=60.7]; Crescentin protein [PF19220.2, score=26.4]; Macoilin family [PF09726.11, score=19.0]} {Human: ENSG00000197616, MYH6, myosin heavy chain 6, [RH, Score=2074, Expect=0.0]; ENSG00000092054, MYH7, myosin heavy chain 7, [RH, Score=2064, Expect=0.0]; ENSG00000125414, MYH2, myosin heavy chain 2, [RH, Score=2019, Expect=0.0]; ENSG00000109061, MYH1, myosin heavy chain 1, [RH, Score=2012, Expect=0.0]; ENSG00000133020, MYH8, myosin heavy chain 8, [RH, Score=2006, Expect=0.0]; ENSG00000264424, MYH4, myosin heavy chain 4, [RH, Score=1991, Expect=0.0]; ENSG00000109063, MYH3, myosin heavy chain 3, [RH, Score=1973, Expect=0.0]} {Mouse: ENSMUSG00000040752, Myh6, myosin, heavy polypeptide 6, cardiac muscle, alpha, [RH, Score=2073, Expect=0.0]; ENSMUSG00000053093, Myh7, myosin, heavy polypeptide 7, cardiac muscle, beta, [RH, Score=2063, Expect=0.0]; ENSMUSG00000057003, Myh4, myosin, heavy polypeptide 4, skeletal muscle, [RH, Score=2039, Expect=0.0]; ENSMUSG00000056328, Myh1, myosin, heavy polypeptide 1, skeletal muscle, adult, [RH, Score=2016, Expect=0.0]; ENSMUSG00000055775, Myh8, myosin, heavy polypeptide 8, skeletal muscle, perinatal, [RH, Score=2014, Expect=0.0]; ENSMUSG00000033196, Myh2, myosin, heavy polypeptide 2, skeletal muscle, adult, [RH, Score=2008, Expect=0.0]; ENSMUSG00000020908, Myh3, myosin, heavy polypeptide 3, skeletal muscle, embryonic, [RH, Score=1981, Expect=0.0]; ENSMUSG00000060180, Myh13, myosin, heavy polypeptide 13, skeletal muscle, [RH, Score=1978, Expect=0.0]} {Dmel: FBgn0264695, Mhc, Myosin heavy chain, [RH, Score=2100, Expect=0.0]} {Celegans: WBGene00019064, myo-5, MYOsin heavy chain structural genes, [RH, Score=1993, Expect=0.0]} {Smed: dd_Smed_v6_579_0_1, dd_Smed_v6_579_0_1, [RH, Score=2702, Expect=0.0]} {RNA1509_16048, RNA1509_42411} {RNA1310_1388, RNA1509_42411} {RNA1509_42411, RNA815_129.1} |
91. | MligTC455_18333 | 273 | 5.7 | Mlig455_010935 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.059/0.00307 |
1.87 | - | - | - | - | 0.914 | 0.956 | Mlig455_010935 {REF} {Length: 510} {RNA1310_33328.2} {RNA815_15093.1} | |
92. | MligTC455_40714 | 93 | 1.94 | Mlig455_008848 | Neo: - Age: - Region-enriched R2: 5.100/0.02617 |
1.869 | - | - | - | - | 0.918 | 0.951 | Mlig455_008848 {REF} {Length: 2258} {RNA1310_21537} {RNA815_13165} | |
93. | MligTC455_15883 | 95 | 1.98 | Mlig455_020080, Mlig455_040893 | Neo: - Age: - |
1.868 | - | - | - | - | 0.997 | 0.871 | Mlig455_020080 {REF} {Length: 1487} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=20.9]} {RNA1310_27849} {RNA815_37376} Mlig455_040893 {REF} {Length: 1486} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=21.0]} {RNA1310_27849} {RNA815_37376} |
|
94. | MligTC455_41448 | 192 | 4.01 | Mlig455_066626 | Neo: - Age: - Region-specific R2: 6.449 Region-enriched R2: 4.988/0.02499 |
1.868 | 0.913 | - | - | - | 0.955 | - | Mlig455_066626 {REF} {Length: 987} {Pfam: F5/8 type C domain [PF00754.27, score=25.0]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=52.4, Expect=8e-09]} {RNA1509_36923} {RNA1310_37535} {RNA815_20943} | |
95. | MligTC455_46581 | 31 | 0.64 | Mlig455_042524 | Neo: - Age: - |
1.868 | 1.000 | - | - | - | 0.868 | - | Mlig455_042524 {REF} {Length: 975} {RNA1509_46101} {RNA1310_32444} {RNA815_42659} | |
96. | MligTC455_49824 | 466 | 9.71 | Mlig455_036536 | Neo: - Age: - Region-specific R2: 4.841 Region-enriched R2: 3.862/0.00010 |
1.868 | - | - | - | - | 0.893 | 0.975 | Mlig455_036536 {REF} {Length: 1139} {Pfam: Nucleoporin FG repeat region [PF13634.8, score=21.2]} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [RH, Score=49.3, Expect=7e-08]} {RNA1509_18714, RNA1509_59524} {RNA1310_41906, RNA1509_18714, RNA1509_59524} {RNA1509_18714, RNA1509_59524, RNA815_24488} | |
97. | MligTC455_52223 | 30 | 0.62 | Mlig455_029799 | Neo: - Age: - |
GLRA2 | 1.868 | - | - | - | - | 0.914 | 0.954 | Mlig455_029799 {REF} {Length: 3197} {tRNA: Val(CAC),pseudo, score=27.6} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=152.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=122.6]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [RH, Score=350, Expect=1e-116]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [RH, Score=345, Expect=4e-115]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [RH, Score=338, Expect=3e-112]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [RH, Score=345, Expect=3e-115]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [RH, Score=342, Expect=2e-113]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [RH, Score=337, Expect=9e-112]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [RH, Score=334, Expect=1e-110]} {Dmel: FBgn0024963, GluClalpha, [RH, Score=301, Expect=8e-98]} {Celegans: WBGene00000232, avr-14, Inhibitory amino acid receptor subunit gbr-2A, [RH, Score=274, Expect=3e-88]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=265, Expect=1e-84]} {RNA1509_44790} {RNA1310_18585} {RNA815_38424} |
98. | MligTC455_15332 | 44 | 0.93 | Mlig455_062622, Mlig455_067527 | Neo: - Age: - Region-enriched R2: 7.516/0.00418 |
ASIC4 | 1.867 | 0.985 | - | - | - | 0.882 | - | Mlig455_062622 {REF} {Length: 2228} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=73.0]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=47.4, Expect=7e-06]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=51.6, Expect=2e-07]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=55.8, Expect=3e-09]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.1, Expect=2e-08]} {RNA1310_17847} {RNA815_27317} Mlig455_067527 {REF} {Length: 1916} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=147.3]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=50.1, Expect=1e-05]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=50.8, Expect=3e-06]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.5, Expect=2e-07]} {RNA1310_17847} {RNA815_27317} |
99. | MligTC455_23101 | 397 | 8.28 | Mlig455_048080 | Neo: - Age: - Region-enriched R2: 3.122/0.00807 |
1.867 | 0.972 | - | - | - | 0.895 | - | Mlig455_048080 {REF} {Length: 721} {TRANSSPLICED} {RNA1509_16955} {RNA1310_49452, RNA1509_16955} {RNA1509_16955, RNA815_4585} | |
100. | MligTC455_33552 | 905 | 18.86 | Mlig455_014406, Mlig455_070160 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.705/0.03873 |
KCNH1 | 1.867 | - | - | - | - | 0.916 | 0.951 | Mlig455_014406 {REF} {Length: 5774} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=54.1]} {Human: ENSG00000143473, KCNH1, potassium voltage-gated channel subfamily H member 1, [Score=269, Expect=1e-82]; ENSG00000283965, KCNH1, potassium voltage-gated channel subfamily H member 1, [Score=269, Expect=1e-82]; ENSG00000140015, KCNH5, potassium voltage-gated channel subfamily H member 5, [Score=256, Expect=1e-74]} {Mouse: ENSMUSG00000058248, Kcnh1, potassium voltage-gated channel, subfamily H (eag-related), member 1, [Score=267, Expect=4e-79]; ENSMUSG00000034402, Kcnh5, potassium voltage-gated channel, subfamily H (eag-related), member 5, [Score=256, Expect=3e-75]} {Dmel: FBgn0000535, eag, ether a go-go, [Score=283, Expect=5e-84]} {Celegans: WBGene00001171, egl-2, EAG K+ channel EGL-2, [Score=240, Expect=1e-69]} {Smed: dd_Smed_v6_23063_0_1, dd_Smed_v6_23063_0_1, [Score=283, Expect=7e-86]} {RNA1509_16580} {RNA1310_9615} {RNA815_20522} Mlig455_070160 {REF} {Length: 3641} {Pfam: Ion transport protein [PF00520.33, score=111.5]; Cyclic nucleotide-binding domain [PF00027.31, score=53.3]; Ion channel [PF07885.18, score=40.6]} {Human: ENSG00000143473, KCNH1, potassium voltage-gated channel subfamily H member 1, [Score=795, Expect=0.0]; ENSG00000283965, KCNH1, potassium voltage-gated channel subfamily H member 1, [Score=795, Expect=0.0]; ENSG00000140015, KCNH5, potassium voltage-gated channel subfamily H member 5, [Score=771, Expect=0.0]} {Mouse: ENSMUSG00000058248, Kcnh1, potassium voltage-gated channel, subfamily H (eag-related), member 1, [Score=794, Expect=0.0]; ENSMUSG00000034402, Kcnh5, potassium voltage-gated channel, subfamily H (eag-related), member 5, [Score=770, Expect=0.0]} {Dmel: FBgn0000535, eag, ether a go-go, [Score=838, Expect=0.0]} {Celegans: WBGene00001171, egl-2, EAG K+ channel EGL-2, [Score=688, Expect=0.0]} {Smed: dd_Smed_v6_18793_0_1, dd_Smed_v6_18793_0_1, [Score=895, Expect=0.0]} {RNA1509_16580} {RNA1310_6070} {RNA815_18231} |